Flyte Aviation, Inc.

Catheter Precision designs, manufactures, and sells medical devices for cardiac electrophysiology procedures, primarily through direct sales in the United States and distributor partnerships internationally. The company's flagship VIVO System is an FDA-cleared, non-invasive 3D cardiac mapping platform that localizes the origin of irregular heart rhythms prior to ablation procedures using proprietary algorithms that combine patient imaging and electrocardiogram data. The company also markets LockeT, a wound-closure retention device, and holds stakes in subsidiaries developing heart-failure and cardiac-mapping technologies. Revenue derives from product sales and licensing royalties, with the addressable market consisting of the thousands of hospital electrophysiology labs performing hundreds of thousands of ablation procedures annually in a sector experiencing sustained growth driven by rising heart disease prevalence and evolving clinical guidelines.